24 September 2017
News and Views
Links and Services
A study in this month's Gastroenterology investigates a new risk-stratification biomarker panel for Barrett's esophagus.
The risk of progression of Barrett's esophagus to esophageal adenocarcinoma is low and difficult
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors